STAT3 Signaling in Oral Squamous Cell Carcinoma: Mechanisms, Tumor Microenvironment, Therapy Resistance, and Therapeutic Targeting

Oral squamous cell carcinoma (OSCC) remains a major clinical challenge because of late diagnosis, frequent recurrence, metastatic spread, and resistance to chemotherapy and radiotherapy. Signal transducer and activator of transcription 3 (STAT3) is a central signaling hub that integrates cytokine-, growth factor-, metabolic-, and stress-derived inputs in both malignant cells and the tumor microenvironment. This review summarizes canonical and non-canonical STAT3 activation and examines its contribution to OSCC initiation and progression. Persistent STAT3 signaling promotes proliferation, survival, epithelial–mesenchymal plasticity, invasion, angiogenesis, cancer stemness, metabolic adaptation, immune evasion, and resistance to treatment. Its activity is sustained by IL-6/JAK signaling, receptor and non-receptor tyrosine kinases, loss of negative regulators, non-coding RNAs, and reciprocal interactions with fibroblasts, macrophages, neutrophils, mesenchymal stromal cells, and suppressive myeloid populations. Therapeutic approaches include IL-6/JAK blockade, direct or proximal STAT3 inhibitors, decoy oligonucleotides, natural and repurposed compounds, and combinations with chemotherapy, radiotherapy, or immune-checkpoint inhibition. Although preclinical evidence is substantial, clinical translation remains limited by pathway heterogeneity, incomplete drug selectivity, systemic toxicity, and the absence of validated predictive biomarkers. Biomarker-guided trials and pharmacodynamically verified combination strategies are therefore required to establish STAT3 as a clinically actionable target in OSCC.

Authors

Institutions

Publication Details

Journal
Medical Sciences
Published
2026-11-17
DOI
https://doi.org/10.3390/medsci14070793
Primary Topic
Cytokine Signaling Pathways and Interactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

STAT3 Signaling in Oral Squamous Cell Carcinoma: Mechanisms, Tumor Microenvironment, Therapy Resistance, and Therapeutic Targeting

Giovanni Tossetta, Roberto Campagna, Alessandro Polizzi, Gaetano Isola et al.
1 links
Medical Sciences
Cytokine Signaling Pathways and Interactions
article

STAT3 Signaling in Oral Squamous Cell Carcinoma: Mechanisms, Tumor Microenvironment, Therapy Resistance, and Therapeutic Targeting

Giovanni Tossetta, Roberto Campagna, Alessandro Polizzi, Gaetano Isola, Magdalena Smolik
article en

Abstract

Oral squamous cell carcinoma (OSCC) remains a major clinical challenge because of late diagnosis, frequent recurrence, metastatic spread, and resistance to chemotherapy and radiotherapy. Signal transducer and activator of transcription 3 (STAT3) is a central signaling hub that integrates cytokine-, growth factor-, metabolic-, and stress-derived inputs in both malignant cells and the tumor microenvironment. This review summarizes canonical and non-canonical STAT3 activation and examines its contribution to OSCC initiation and progression. Persistent STAT3 signaling promotes proliferation, survival, epithelial–mesenchymal plasticity, invasion, angiogenesis, cancer stemness, metabolic adaptation, immune evasion, and resistance to treatment. Its activity is sustained by IL-6/JAK signaling, receptor and non-receptor tyrosine kinases, loss of negative regulators, non-coding RNAs, and reciprocal interactions with fibroblasts, macrophages, neutrophils, mesenchymal stromal cells, and suppressive myeloid populations. Therapeutic approaches include IL-6/JAK blockade, direct or proximal STAT3 inhibitors, decoy oligonucleotides, natural and repurposed compounds, and combinations with chemotherapy, radiotherapy, or immune-checkpoint inhibition. Although preclinical evidence is substantial, clinical translation remains limited by pathway heterogeneity, incomplete drug selectivity, systemic toxicity, and the absence of validated predictive biomarkers. Biomarker-guided trials and pharmacodynamically verified combination strategies are therefore required to establish STAT3 as a clinically actionable target in OSCC.

Medical SciencesVol. 14(7)
Jagiellonian University (PL), San Raffaele University of Rome (IT), University of Catania (IT)
Good health and well-being
Cytokine Signaling Pathways and Interactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon